BioSpace News Archive

Dr. Isaac Rodriguez-Chavez brings vast expertise in regulatory compliance and clinical research methodology to PRA’s industry-leading DCT practice

Codiak BioSciences, Inc. (NASDAQ: CDAK), a clinical-stage company focused on pioneering the development of exosome-based therapeutics, today reported third quarter 2020 financial results and operational progress.

Immunomic Therapeutics, Inc., (“ITI”), and CoImmune, Inc. (“CoImmune”), a privately held clinical-stage immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, announced today that the companies have entered into a license agreement for ITI to use CoImmune’s proprietary dendritic cell process for certain ITI cell therapy vaccine programs

AbCellera, a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease, and Invetx, a pioneer in protein-based therapeutics for animal health, announced the companies have expanded their agreement to generate therapeutic antibody candidates for serious and chronic conditions in animal health.

Matinas BioPharma Holdings, Inc. (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to advance standards of care in areas of significant unmet medical need, has been invited to participate in a fireside chat as part of the Piper Sandler 32nd Annual Virtual Healthcare Conference,

Oragenics, Inc. a company focused on the creation of the Terra CoV-2 vaccine candidate to combat the novel coronavirus pandemic, announced that it has commenced a proposed underwritten public offering of common stock of the Company.

Aptevo Therapeutics Inc. announced that it has received an unsolicited non-binding indication of interest from Tang Capital Partners, LP expressing its interest in acquiring all of the outstanding shares of Aptevo that it does not already own for $50.00 per share in cash.

Geron Corporation reported that it has granted a non-statutory stock option to purchase an aggregate of 80,000 shares of Geron common stock as an inducement to a newly-hired employee in connection with commencement of employment with the Company.

The company is expanding services to increase access to care and decrease wait times for dental patients in the Bluegrass State.

The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded the 2020 Robert A. Pritzker Prize for Leadership in Parkinson’s Research to Caroline Tanner , MD, PhD, professor of neurology at the Weill Institute for Neurosciences, University of California, San Francisco . The Prize recognizes researchers who make exceptio